United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 781,500 | 790,200 | 799,500 | 798,600 | 794,400 |
| Cost of Goods | 133,400 | 103,400 | 100,900 | 87,600 | 92,500 |
| Gross Profit | 648,100 | 686,800 | 698,600 | 711,000 | 701,900 |
| Operating Expenses | 322,700 | 330,500 | 311,000 | 347,100 | 319,600 |
| Operating Income | 325,800 | 356,700 | 388,500 | 364,500 | 382,800 |
| Interest Expense | 3,000 | 3,100 | 3,000 | 7,300 | 6,100 |
| Other Income | -4,500 | 90,400 | 52,500 | 51,200 | 46,800 |
| Pre-tax Income | 318,300 | 444,000 | 438,000 | 408,400 | 423,500 |
| Income Tax | 43,400 | 79,700 | 99,300 | 98,900 | 101,300 |
| Net Income Continuous | 274,900 | 364,300 | 338,700 | 309,500 | 322,200 |
| Net Income | $274,900 | $364,300 | $338,700 | $309,500 | $322,200 |
| EPS Basic Total Ops | 6.32 | 8.36 | 7.73 | 6.86 | 7.18 |
| EPS Basic Continuous Ops | 6.32 | 8.36 | 7.73 | 6.86 | 7.18 |
| EPS Diluted Total Ops | 5.82 | 7.66 | 7.16 | 6.41 | 6.63 |
| EPS Diluted Continuous Ops | 5.82 | 7.67 | 7.16 | 6.41 | 6.63 |
| EPS Diluted Before Non-Recurring Items | N/A | 7.70 | 7.16 | 6.41 | 6.63 |
| EBITDA(a) | $348,400 | $379,500 | $410,400 | $385,600 | $402,600 |